Physician profile
John J James
NPI 1881835510
$13,133.15
in general payments reported to CMS, 2019-2025
9 companies · $2,532 in 2025
The $2,532 reported for 2025 was more than what 98% of Sports Medicine (Emergency Medicine) providers received nationally (typical 2025 total: $100).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $158 · 2021: $2,502 · 2022: $2,437 · 2023: $2,746 · 2024: $2,544 · 2025: $2,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $7,200 · Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $7,200.00 |
| Food and Beverage | $622.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $12,000.00 | 2021-2025 | Venacure 1470 Pro |
| Tactile Systems Technology INC | $431.70 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Horizon Therapeutics Plc | $429.15 | 2019-2021 | |
| Medtronic, INC. | $88.27 | 2021-2023 | Venaseal |
| Amneal Pharmaceuticals LLC | $84.88 | 2024-2025 | Unithroid |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $33.20 | 2024-2025 | Caplyta |
| Koya Medical, INC. | $31.21 | 2025 | Koya Medical, Dayspring |
| Depuy Synthes Sales INC. | $20.52 | 2021 | |
| Abbott Laboratories | $14.22 | 2023 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.